PLP Growth Research Peptide is a premium-quality research compound manufactured to high purity standards. Designed for laboratory and scientific research applications
CagriTirz pairs cagrilintide with tirzepatide (GLP-2T), a dual GLP-1 and GIP receptor agonist, creating a three-pathway metabolic combination. Tirzepatide’s dual incretin action drives robust improvements in insulin sensitivity and energy balance, while cagrilintide adds amylin-mediated appetite suppression and glucagon control. This multi-receptor approach is being investigated as a strategy to maximize metabolic outcomes through complementary, non-redundant mechanisms.
| 1+10mg |
|
|
|
|
|
|
| 2+20mg |
|
|
|
|
|
|
1-49 units
| Amount | Price |
|---|---|
| 1+10mg | |
| 2+20mg |
50-99 units
| Amount | Price |
|---|---|
| 1+10mg | |
| 2+20mg |
100-499 units
| Amount | Price |
|---|---|
| 1+10mg | |
| 2+20mg |
500-999 units
| Amount | Price |
|---|---|
| 1+10mg | |
| 2+20mg |
1000-2499 units
| Amount | Price |
|---|---|
| 1+10mg | |
| 2+20mg |
2500+ units
| Amount | Price |
|---|---|
| 1+10mg | |
| 2+20mg |